These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 29960168)

  • 1. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
    Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
    Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
    Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
    Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-? regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma.
    Du M; Chen W; Zhang W; Tian XK; Wang T; Wu J; Gu J; Zhang N; Lu ZW; Qian LX; Fei Q; Wang Y; Peng F; He X; Yin L
    Biomed Pharmacother; 2018 Mar; 99():688-696. PubMed ID: 29710466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
    Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
    BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
    Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
    Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.
    Tian X; Fei Q; Du M; Zhu H; Ye J; Qian L; Lu Z; Zhang W; Wang Y; Peng F; Chen J; Liu B; Li Q; He X; Yin L
    Cancer Med; 2019 Mar; 8(3):1197-1208. PubMed ID: 30741461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
    Zhang T; Yin P; Zhang Z; Xu B; Che D; Dai Z; Dong C; Jiang P; Hong H; Yang Z; Zhou T; Shao J; Xu Z; Yang X; Gao G
    Cell Death Dis; 2017 Jun; 8(6):e2838. PubMed ID: 28569772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition Through TGF-β/Smad4 Axis in Nasopharyngeal Carcinoma.
    Chen Q; Wang Y; Li F; Cheng X; Xiao Y; Chen S; Xiao B; Tao Z
    Anticancer Agents Med Chem; 2022; 22(6):1080-1090. PubMed ID: 34229595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion.
    Cheng HP; Huang CJ; Tsai ML; Ong HT; Cheong SK; Choo KB; Chiou SH
    Int J Med Sci; 2021; 18(8):1798-1809. PubMed ID: 33746597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y; Wang M; Li X; Cui F
    Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.
    Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D
    Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
    Qian W; Ren Z; Lu X
    Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β.
    Zhao L; Lin L; Pan C; Shi M; Liao Y; Bin J; Liao W
    Oncotarget; 2015; 6(12):9781-93. PubMed ID: 25909165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placenta specific 8 gene induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via the TGF-β/Smad pathway.
    Huang ML; Zou Y; Yang R; Jiang Y; Sheng JF; Han JB; Kong YG; Tao ZZ; Chen SM
    Exp Cell Res; 2019 Jan; 374(1):172-180. PubMed ID: 30496758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
    Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
    Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
    Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of flotillin-1 promotes invasion and metastasis by activating TGF-β signaling in nasopharyngeal carcinoma.
    Cao S; Cui Y; Xiao H; Mai M; Wang C; Xie S; Yang J; Wu S; Li J; Song L; Guo X; Lin C
    Oncotarget; 2016 Jan; 7(4):4252-64. PubMed ID: 26646322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of Smad4 by miR‑205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines.
    Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z
    Int J Oncol; 2016 Aug; 49(2):700-8. PubMed ID: 27279345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.